FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2083329632> ?p ?o ?g. }

• W2083329632 endingPage "2243" @default.
• W2083329632 startingPage "2238" @default.
• W2083329632 abstract "A total of 56 healthy Japanese males were enrolled in single- or multiple- dose pharmacokinetic trials of intravenous lansoprazole administration. The population pharmacokinetics of the drug was evaluated using nonlinear mixed effects model (NONMEM) software. In addition, the effect of CYP2C19 polymorphism on proton pump inhibition by lansoprazole was investigated using 24-h intragastric pH monitoring in the 32 subjects. Time course of serum lansoprazole concentration following intravenous short infusion was well described by a 2-compartment model. The mean volume of the central and peripheral compartments was 0.110 and 0.201 l/kg, respectively. The mean inter-compartment clearance was estimated to be 0.0882 l/h/kg. The population mean value of systemic clearance in the homoEM (CYP2C19 1/ 1), heteroEM (CYP2C19 1/2 and 1/3), and PM (CYP2C19 2/2, 2/3, and 3/3) groups was 0.179, 0.109, and 0.038 l/h/kg, respectively. The mean intragastric pH following twice-daily doses of 30 mg lansoprazole was approximately 6, 5, and 4 in the PM, heteroEM, and homoEM groups, respectively. These findings indicate that large interindividual variability exists in the pharmacokinetics of intravenously administered lansoprazole, but that twice-daily infusion of a 30 mg dose leads to significant and sustained proton pump inhibition, even in the homoEM group, despite the short elimination half-life of the drug." @default.
• W2083329632 created "2016-06-24" @default.
• W2083329632 creator A5000351337 @default.
• W2083329632 creator A5002820431 @default.
• W2083329632 creator A5010302035 @default.
• W2083329632 creator A5041304842 @default.
• W2083329632 creator A5048577166 @default.
• W2083329632 creator A5055685005 @default.
• W2083329632 creator A5065298749 @default.
• W2083329632 creator A5070089858 @default.
• W2083329632 creator A5075241995 @default.
• W2083329632 creator A5087359493 @default.
• W2083329632 date "2007-01-01" @default.
• W2083329632 modified "2023-10-06" @default.
• W2083329632 title "Population Pharmacokinetics and Proton Pump Inhibitory Effects of Intravenous Lansoprazole in Healthy Japanese Males" @default.
• W2083329632 cites W1528930311 @default.
• W2083329632 cites W1550666015 @default.
• W2083329632 cites W1905141048 @default.
• W2083329632 cites W1912895873 @default.
• W2083329632 cites W1922033845 @default.
• W2083329632 cites W1946004087 @default.
• W2083329632 cites W1964067924 @default.
• W2083329632 cites W1969244190 @default.
• W2083329632 cites W1971883525 @default.
• W2083329632 cites W2004794401 @default.
• W2083329632 cites W2015402531 @default.
• W2083329632 cites W2027852470 @default.
• W2083329632 cites W2056770708 @default.
• W2083329632 cites W2063416287 @default.
• W2083329632 cites W2084723116 @default.
• W2083329632 cites W2119619071 @default.
• W2083329632 cites W2123254230 @default.
• W2083329632 cites W2138959532 @default.
• W2083329632 cites W2159435181 @default.
• W2083329632 cites W2288991238 @default.
• W2083329632 cites W2323070120 @default.
• W2083329632 cites W253228849 @default.
• W2083329632 doi "https://doi.org/10.1248/bpb.30.2238" @default.
• W2083329632 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18057705" @default.
• W2083329632 hasPublicationYear "2007" @default.
• W2083329632 type Work @default.
• W2083329632 sameAs 2083329632 @default.
• W2083329632 citedByCount "12" @default.
• W2083329632 countsByYear W20833296322012 @default.
• W2083329632 countsByYear W20833296322013 @default.
• W2083329632 countsByYear W20833296322014 @default.
• W2083329632 countsByYear W20833296322016 @default.
• W2083329632 countsByYear W20833296322019 @default.
• W2083329632 countsByYear W20833296322020 @default.
• W2083329632 crossrefType "journal-article" @default.
• W2083329632 hasAuthorship W2083329632A5000351337 @default.
• W2083329632 hasAuthorship W2083329632A5002820431 @default.
• W2083329632 hasAuthorship W2083329632A5010302035 @default.
• W2083329632 hasAuthorship W2083329632A5041304842 @default.
• W2083329632 hasAuthorship W2083329632A5048577166 @default.
• W2083329632 hasAuthorship W2083329632A5055685005 @default.
• W2083329632 hasAuthorship W2083329632A5065298749 @default.
• W2083329632 hasAuthorship W2083329632A5070089858 @default.
• W2083329632 hasAuthorship W2083329632A5075241995 @default.
• W2083329632 hasAuthorship W2083329632A5087359493 @default.
• W2083329632 hasBestOaLocation W20833296321 @default.
• W2083329632 hasConcept C112705442 @default.
• W2083329632 hasConcept C126322002 @default.
• W2083329632 hasConcept C140840227 @default.
• W2083329632 hasConcept C185592680 @default.
• W2083329632 hasConcept C2776239304 @default.
• W2083329632 hasConcept C2777498785 @default.
• W2083329632 hasConcept C2778715759 @default.
• W2083329632 hasConcept C2781025758 @default.
• W2083329632 hasConcept C2908647359 @default.
• W2083329632 hasConcept C3020755252 @default.
• W2083329632 hasConcept C526171541 @default.
• W2083329632 hasConcept C62231903 @default.
• W2083329632 hasConcept C71924100 @default.
• W2083329632 hasConcept C90924648 @default.
• W2083329632 hasConcept C98274493 @default.
• W2083329632 hasConcept C99454951 @default.
• W2083329632 hasConceptScore W2083329632C112705442 @default.
• W2083329632 hasConceptScore W2083329632C126322002 @default.
• W2083329632 hasConceptScore W2083329632C140840227 @default.
• W2083329632 hasConceptScore W2083329632C185592680 @default.
• W2083329632 hasConceptScore W2083329632C2776239304 @default.
• W2083329632 hasConceptScore W2083329632C2777498785 @default.
• W2083329632 hasConceptScore W2083329632C2778715759 @default.
• W2083329632 hasConceptScore W2083329632C2781025758 @default.
• W2083329632 hasConceptScore W2083329632C2908647359 @default.
• W2083329632 hasConceptScore W2083329632C3020755252 @default.
• W2083329632 hasConceptScore W2083329632C526171541 @default.
• W2083329632 hasConceptScore W2083329632C62231903 @default.
• W2083329632 hasConceptScore W2083329632C71924100 @default.
• W2083329632 hasConceptScore W2083329632C90924648 @default.
• W2083329632 hasConceptScore W2083329632C98274493 @default.
• W2083329632 hasConceptScore W2083329632C99454951 @default.
• W2083329632 hasIssue "12" @default.
• W2083329632 hasLocation W20833296321 @default.
• W2083329632 hasLocation W20833296322 @default.
• W2083329632 hasOpenAccess W2083329632 @default.
• W2083329632 hasPrimaryLocation W20833296321 @default.

• next